Literature DB >> 2414269

Characterization of the in vivo RNA product of the pOUT promoter of IS10R.

Y Lee, F J Schmidt.   

Abstract

We characterized a single RNA species (RNAout1) which was the major in vivo RNA made from pOUT of IS10R. RNAout1 was 70 nucleotides long; its 5' end corresponded exactly to the in vitro start of pOUT transcription. The concentration of RNAout1 was estimated at 5 to 10 molecules per cell containing the single-copy plasmid NR1. RNA sequences from pOUT of IS10L were detected at a much lower (less than one molecule per cell) steady-state concentration and may be preferentially degraded in vivo. We suggest that the low level of the IS10L transcript led to the inability of IS10L sequences to translationally inhibit Tn10 transposition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414269      PMCID: PMC214288          DOI: 10.1128/jb.164.2.556-562.1985

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Mutagenesis by insertion of a drug-resistance element carrying an inverted repetition.

Authors:  N Kleckner; R K Chan; B K Tye; D Botstein
Journal:  J Mol Biol       Date:  1975-10-05       Impact factor: 5.469

2.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

3.  Metabolism of ribosomal RNA in mutants of Escherichia coli doubly defective in ribonuclease III and the transcription termination factor rho.

Authors:  D Apirion; J Neil; T S Ko; N Watson
Journal:  Genetics       Date:  1978-09       Impact factor: 4.562

Review 4.  Minor components in transfer RNA: their characterization, location, and function.

Authors:  S Nishimura
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1972

5.  Improved estimation of secondary structure in ribonucleic acids.

Authors:  I Tinoco; P N Borer; B Dengler; M D Levin; O C Uhlenbeck; D M Crothers; J Bralla
Journal:  Nat New Biol       Date:  1973-11-14

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  The enzymatic preparation of [alpha-32P]ATP, [alpha-32P]GTP, [32P]cAMP, and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases.

Authors:  R A Johnson; T F Walseth
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

8.  Organization of structural and regulatory genes that mediate tetracycline resistance in transposon Tn10.

Authors:  R A Jorgensen; W S Reznikoff
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

9.  Low molecular weight RNA species encoded by a multiple drug resistance plasmid.

Authors:  M De Wilde; J E Davies; F J Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

View more
  4 in total

1.  Structural analysis of an RNA molecule involved in replication control of plasmid R1.

Authors:  E Gerhart; H Wagner; K Nordström
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

2.  Regulation of 6S RNA biogenesis by switching utilization of both sigma factors and endoribonucleases.

Authors:  Kwang-sun Kim; Younghoon Lee
Journal:  Nucleic Acids Res       Date:  2004-11-18       Impact factor: 16.971

3.  The IS10 antisense RNA blocks ribosome binding at the transposase translation initiation site.

Authors:  C Ma; R W Simons
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

4.  The unusual stability of the IS10 anti-sense RNA is critical for its function and is determined by the structure of its stem-domain.

Authors:  C C Case; S M Roels; P D Jensen; J Lee; N Kleckner; R W Simons
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.